Radiopharm Theranostics reports positive Phase 1 trial results
Radiopharm Theranostics (ASX:RAD) unveiled initial data from its Phase 1 "HEAT" first-in-human clinical trial.

TV presenter and finance editor at Grafa, with a Master’s in Commerce from UWA and diverse industry experience in finance, insurance, and media.
Radiopharm Theranostics (ASX:RAD) unveiled initial data from its Phase 1 "HEAT" first-in-human clinical trial.
DXN (ASX:DXN) has secured a landmark $5.3 million contract with a prominent global internet company.
Australian logistics giant Qube Holdings (ASX:QUB) has flagged a potential $20 million dent in its earnings for the 2026 financial year.
ANI Pharmaceuticals (NASDAQ:ANIP) announced today the U.S. Food and Drug Administration (FDA) approval and commercial launch of Pimozide Tablets in 1 mg and 2 mg strengths.
Surf Air Mobility (NYSE:SRFM), a leading regional air mobility platform, today announced a major upward revision to its financial outlook for the 2026 fiscal year.
Ennis (NYSE:EBF), a manufacturer of printed business products and apparel, today announced financial results for the fourth quarter and the full fiscal year ended February 28, 2026.
Nanobiotix (NASDAQ:NBTX), a late-clinical stage biotechnology company, announced the presentation of new preclinical data today at the 2026 Annual Meeting of the American Association for Cancer Research (AACR).
Prediction market platform Polymarket is reportedly in talks to raise $400 million at a $15 billion valuation, as institutional capital continues to flow into the fast-growing sector.
Nvidia has released Nemotron 3 Super, a 120 billion-parameter open AI model designed to improve efficiency and reduce costs for large-scale agentic workloads.
Michael Saylor signalled another potential major Bitcoin purchase, reinforcing expectations of continued accumulation by Strategy.